The mRNA expression of IGF2BP3 in PBMCs and MH7A was increased, similar to our sequence data, while after treatment with different concentrations of TP, IGF2BP3 mRNA level was decreased, demonstrating that IGF2BP3 might be a new target of TP, which provide a possible strategy for the treatment of RA. Here, IGF2BP3 is linked to rheumatoid arthritis.